Evidence map›Paper›PMID 40723842›Full record

ReviewBiomolecules2025

Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy.

Wanjuan Pei, Ling Dai, Mingxiao Li, Sihui Cao, Yili Xiao, Yan Yang, Minghao Ma, Minjie Deng, Yang Mo, Mi Liu

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wanjuan PeiMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0009-0000-3851-9906
Ling DaiMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Mingxiao LiMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Sihui CaoCollege of Acupuncture and Moxibustion, Hunan University of Chinese Medicine, Changsha 410208, China.
Yili XiaoMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Yan YangMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Minghao MaMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Minjie DengMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0009-0004-7733-2174
Yang MoMedical College, Hunan University of Chinese Medicine, Changsha 410208, China.
Mi LiuCollege of Acupuncture and Moxibustion, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0003-4860-7533

Funding

the 2024 Provincial College Students Innovation and Entrepreneurship Training Program Project at Hunan University of Chinese Medicine No. S202410541114the Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine No. [2021] 356, Hunan Provincial Department of Education Noticethe science and technology innovation Program of Hunan Province No. 2024JK2132, No. 2024RC1061the State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program National Letter of Traditional Chinese Medicine Education [2022] 256
6 · The paper itself

Abstract

Breast cancer is the leading threat to the health of women, with a rising global incidence linked to social and psychological factors. Among its subtypes, triple-negative breast cancer (TNBC), which lacks

Indexed as

MitochondriaPrecision MedicineTriple Negative Breast NeoplasmsAnimalsDrug Resistance, NeoplasmFemaleHumansimmune evasionmaintenance of stemnessmetabolic reprogrammingmitochondrial quality controlTNBC

Identifiers

PMID40723842
PMCPMC12292282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.